UW Carbone Survivorship Program


The UW Carbone Survivorship Program advances research and care to support cancer survivors and their families through health system innovation. We focus on integrating survivorship into clinical practice, improving quality of life, shaping health policy, and training healthcare professionals through in-person and online education.

We bridge oncology, primary care, and specialty services to deliver patient-centered, coordinated care tailored to each cancer type. Our team is committed to promoting health equity by addressing social determinants that impact access to survivorship care.

Cancer survivors are individuals from the moment of diagnosis through the rest of their lives. Due to an aging population, rising cancer rates, and advances in detection and treatment, the number of survivors in the U.S. is expected to exceed 22 million by 2030.

This growing population highlights the urgent need to address the long-term and late effects of cancer and its treatments. At the same time, improving care coordination between oncology and primary care is essential to ensure survivors receive comprehensive, high-quality support throughout their journey.

UW Carbone Survivorship Program Lecture
two researchers standing in front of research findings poster

Recent Publications

|

  1. Reddy, Apoorva C et al. “The effects of tetrahydrocannabinol and cannabidiol on sleep in cancer patients.” Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 28,4 (2026): 1431-1443. Doi:10.1007/s12094-025-04069-8. Link https://pubmed.ncbi.nlm.nih.gov/41120744/
  2. Barbosa Carroll, Cibele et al. “Cancer Survivorship Practices Among Cancer Care Providers and Cancer Centers in Brazil: Results From a National Survey.” JCO global oncology vol. 12 (2026): e2500414. Doi:10.1200/GO-25-00414. Link https://pubmed.ncbi.nlm.nih.gov/41759052/
  3. Pophali, Priyanka A et al. “Bridging the Gap: Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: Long-Term Benefit, Yet Real-World Complexity.” Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 44,2 (2026): 76-80. Doi:10.1200/JCO-25-02323. Link https://pubmed.ncbi.nlm.nih.gov/41370745/

  1. Lawler, Thomas et al. “Self-efficacy for cancer self-management in the context of COVID-19: a cross-sectional survey study.” Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 33,10 843. 10 Sep. 2025, doi:10.1007/s00520-025-09905-9. Link https://pubmed.ncbi.nlm.nih.gov/40928529/
  2. Agnew, Megan et al. “Changes in physical activity since cancer diagnosis and associations with health-related quality of life: a study of adults living with advanced cancer.” Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 33,2 131. 30 Jan. 2025, doi:10.1007/s00520-025-09196-0. Link https://pubmed.ncbi.nlm.nih.gov/39885059/
  3. Schumacher, Jessica R et al. “Ongoing Symptoms and Concerns Experienced by Low-Risk Breast Cancer Survivors Following Active Treatment.” Annals of surgical oncology vol. 32,5 (2025): 3252-3259. Doi:10.1245/s10434-025-16959-w. Link https://pubmed.ncbi.nlm.nih.gov/39881007/